Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity

NCT00340080 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1806

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Abacavir

Sponsor

GlaxoSmithKline